摘要
目的观察临床配合耳穴贴压疗法能否有效减少2型糖尿病的用药剂量,旨在验证耳穴贴压治疗糖尿病在社区内推广的可行性。方法选择门诊同时服用格列齐特缓释片(60mg/d)和二甲双胍(1g/d)药物的2型糖尿病患者70例,随机分为治疗组和对照组,治疗组将格列齐特缓释片的剂量减半(30mg/d),配合耳穴贴压,测两组患者空腹血糖和餐后2h血糖与治疗前进行比较分析。结果配合耳穴贴压治疗后,治疗组患者空腹、餐后2h血糖与对照组比较差异无统计学意义(P>0.05)。结论配合耳穴贴压治疗糖尿病可减少用药剂量,又能减轻患者的经济负担。
Objective To investigate if clinical addition of auricular point plaster therapy can effectively reduce antidiabetic dosage in type 2 diabetes patients and to validate the feasibility of communal popularization of auricular point plaster therapy for diabetes. Methods Seventy type 2 diabetes outpatients taking Gliclazide sustained release tablets (60 mg/d) and Metformin (1 g/d) simultaneously were enrolled and randomly allocated to treatment and control groups. The dosage of Gliclazide sustained release tablets was halved (30 mg/d) in combination with auricular point plaster therapy in the treatment group. Fasting and 2 hour postprandial blood glucoses of the two groups were measured. A pre-/post-treatment comparison was made. Results After the addition of auricular point plaster therapy,there were no statistically significant differences in fasting and 2 hour postprandial blood glucoses between treatment and control groups (P0.05). Conclusion Adding auricular point plaster therapy for diabetes can reduce both antidiabetic dosage and economic burden on the patients.
出处
《上海针灸杂志》
2010年第6期344-346,共3页
Shanghai Journal of Acupuncture and Moxibustion
关键词
糖尿病
非胰岛素依赖
耳穴贴压
格列齐特缓释片
Diabetes
non-insulin dependenct
Auricular point plaster therapy
Gliclazide sustained release tablets